Results 221 to 230 of about 1,112,190 (273)

Medication Abortion and Uterine Aspiration for Undesired Pregnancy of Unknown Location: A Retrospective Cohort Study.

Contraception, 2023
OBJECTIVE To compare days to diagnosis of pregnancy location for same day medication abortion and same day uterine aspiration with delayed treatment (expectant management) in patients with undesired pregnancy of unknown location (PUL).
Karen Borchert, Chelsea Thibodeau, Paige Varin, H. Wipf, S. Traxler, C. Boraas   +5 more
semanticscholar   +1 more source

Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.

Contraception, 2023
The objective of this Clinical Recommendation is to review relevant literature and provide evidence-based recommendations for medication abortion between 14 0/7 and 27 6/7 weeks of gestation, with a focus on mifepristone-misoprostol and misoprostol-only ...
Blake Zwerling, A. Edelman, Anwar Jackson, A. Burke, with the assistance of Malavika Prabhu   +4 more
semanticscholar   +1 more source

Counseling for medical abortion

American Journal of Obstetrics and Gynecology, 2000
Counseling and education are correlated with women's satisfaction with all abortion care. They often assume a larger role in medical abortion because the patient is a more active participant in the abortion process. This article aims to enhance the practitioner's expertise in providing the information and care necessary for women considering early ...
openaire   +2 more sources

Perspectives on options for self-sourcing medication abortion after implementation of Texas Senate Bill 8

Contraception
Structured Abstract Objectives: To examine experiences of pregnant Texans who considered self-sourcing medication abortion following the September 2021 implementation of Texas Senate Bill 8, which prohibited abortions after detectable embryonic cardiac ...
Whitney Arey, K. Lerma, Anna Chatillion, Kari White   +3 more
semanticscholar   +1 more source

No-Test Medication Abortion

Obstetrics & Gynecology, 2022
OBJECTIVE: To summarize the effectiveness and safety outcomes of medication abortion performed without prior pelvic examination or ultrasonogram (“no-test medication abortion”). DATA SOURCES: We searched the MEDLINE, Scopus, Web of Science, Cochrane (including ClinicalTrials.gov ...
Marit, Pearlman Shapiro, Divya, Dethier, Melissa, Kahili-Heede, Bliss, Kaneshiro   +3 more
openaire   +2 more sources

Update on Medication Abortion

Journal of Midwifery & Women's Health, 2007
This article provides an overview of medication abortion in the United States 6 years after the approval of mifepristone (RU486; Mifeprex; Danco Laboratories, LLC, New York, NY) by the US Food and Drug Administration (FDA). The adoption of mifepristone is considered in the context of epidemiologic data on abortion, abortion access, and the safety of ...
openaire   +2 more sources

Demand for Medication Abortion Through Telehealth Before and After the Dobbs v. Jackson Supreme Court Decision in States Where Abortion Is Legal.

Women's health issues
OBJECTIVE The provision of medication abortion through telehealth accounts for an increasing share of total abortions in the United States, offering a private and affordable option for patients in both restrictive and supportive states.
Anna E. Fiastro, Elissa Brown, Rebecca Gomperts, Emily M. Godfrey   +3 more
semanticscholar   +1 more source

Telehealth Medication Abortion

Obstetrics and Gynecology
Some patients prefer having abortion medications on hand for a future pregnancy; these individuals do not represent those who traditionally have limited access to abortion care.
Anna E. Fiastro, Elissa Brown, Peyton Smith, Erin K. Thayer, Rebecca Gomperts, Emily M. Godfrey   +5 more
semanticscholar   +1 more source

How Effective Is Misoprostol Alone for Medication Abortion?

NEJM Evidence
With recent severe restrictions to abortion accessibility in the United States and a pending Supreme Court case challenging the Food and Drug Administration's approval of mifepristone, evidence-based strategies to protect and expand access to abortion ...
H. Moseson, Ruvani T. Jayaweera, Sarah E. Baum, Caitlin Gerdts   +3 more
semanticscholar   +1 more source

Exploring the availability and accessibility of medication abortion pills in Delhi, India: A mystery client study in community pharmacies.

Contraception
OBJECTIVES Although medication abortion drugs technically require a prescription in India, research suggests that they are often available directly from pharmacies.
Anvita Dixit, Dipesh Suvarna, R. Deonandan, Angel M. Foster   +3 more
semanticscholar   +1 more source